top of page
gradientForSurfBreak.png

Item List

Dot.la
As COVID Numbers Rise Again, VCs Continue To Be Bullish on Telehealth

Telehealth startup Cerebral entered the medical tech scene two years ago, backed by over $400 million in venture funding and a promise: remote access to mental health professionals and treatment that could help patients with a range of behavioral challenges, from depression to anxiety to ADHD, all bundled in a neat monthly subscription priced at $100 per month.

But by May of this year, Cerebral’s practices began to crumble under scrutiny. The company’s problems accelerated when an ex-executive filed a lawsuit in April alleging he was fired for speaking out against the Cerebral’s tendency to over-prescribe ADHD stimulants. The lawsuit then led to a Justice Department investigation into the company’s “possible violations” of the federal Controlled Substances Act, which is still pending alongside a separate inquiry from the Drug Enforcement Administration.

Recent Posts

Portfolio Company

Carlsmed.png

Marigold Health Secures $11m in Series A Funding to Expand Peer Support
...

Busineswire

Portfolio Company

Carlsmed.png

Materna Medical Launches Groundbreaking Virtual Clinical Trial Evaluating Treatm ...

Yahoo Finance

Portfolio Company

Carlsmed.png


Clarified Precision Medicine, xCures Partner to Improve Clinical Decision Suppo ...

Precision Medicine Online

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page